Trader consensus reflects a 78% market-implied probability for no new CDC Level 4 "Do Not Travel" health warning by December 31, driven by the complete absence of any current Level 4 notices and stable global outbreak surveillance as of early May 2026. Official CDC data shows zero Level 4 or even Level 3 travel health alerts, with recent Level 2 notices—for meningococcal disease in the Democratic Republic of the Congo, yellow fever in Venezuela, and chikungunya in Mayotte—issued in March and not escalating due to contained transmission and vaccination responses. Mpox clade IIb cases exceed 100,000 globally since 2022 but remain managed without extreme risk thresholds met, while CDC affirmed low hantavirus outbreak threat on May 9. Level 4 designations require severe, widespread public health crises like historic Ebola epidemics; no such indicators exist now. Watch WHO weekly reports and CDC updates for any novel pathogen surges that could shift odds before year-end resolution.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · AktualisiertCDC gibt Warnung der Stufe 4 bis zum 31. Dezember aus?
CDC gibt Warnung der Stufe 4 bis zum 31. Dezember aus?
Ja
$71,397 Vol.
$71,397 Vol.
Ja
$71,397 Vol.
$71,397 Vol.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Markt eröffnet: Jan 19, 2026, 3:15 PM ET
Resolver
0x65070BE91...A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Resolver
0x65070BE91...Trader consensus reflects a 78% market-implied probability for no new CDC Level 4 "Do Not Travel" health warning by December 31, driven by the complete absence of any current Level 4 notices and stable global outbreak surveillance as of early May 2026. Official CDC data shows zero Level 4 or even Level 3 travel health alerts, with recent Level 2 notices—for meningococcal disease in the Democratic Republic of the Congo, yellow fever in Venezuela, and chikungunya in Mayotte—issued in March and not escalating due to contained transmission and vaccination responses. Mpox clade IIb cases exceed 100,000 globally since 2022 but remain managed without extreme risk thresholds met, while CDC affirmed low hantavirus outbreak threat on May 9. Level 4 designations require severe, widespread public health crises like historic Ebola epidemics; no such indicators exist now. Watch WHO weekly reports and CDC updates for any novel pathogen surges that could shift odds before year-end resolution.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · Aktualisiert
Vorsicht bei externen Links.
Vorsicht bei externen Links.
Häufig gestellte Fragen